Clinical trials
Phase 2 Hereditary Sensory and Autonomic Neuropathies trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 2 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 8 |
| Recruiting | 5 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 4 |
| Incyte Corporation | 3 |
| Actuate Therapeutics Inc. | 2 |
| EMD Serono Research & Development Institute, Inc. | 2 |
| Novartis Pharmaceuticals | 2 |
| Restorbio Inc. | 2 |
| Aadi Bioscience, Inc. | 1 |
| AllRock Bio, Inc. | 1 |
| AstraZeneca | 1 |
| Bristol-Myers Squibb | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hereditary Sensory and Autonomic Neuropathies | 30 |
| Neoplasm Metastasis | 4 |
| Breast Neoplasms | 3 |
| Neoplasms | 3 |
| COVID-19 | 2 |
| Lung Neoplasms | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Melanoma | 2 |
| Pain | 2 |
| Primary Myelofibrosis | 2 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.